Dr. William W. Seeley's lab at UCSF focuses on understanding the causes of frontotemporal dementia and motor neuron disease, two worsening neurodegenerative disorders. They investigate the role of certain proteins, like TDP-43, that misbehave in these conditions. By studying brain samples, they aim to find new insights that could lead to better treatments for these challenging diseases.

Dr. Karunesh Ganguly's lab at UCSF focuses on developing advanced brain-computer interfaces (BCIs) that can help patients with severe motor disabilities regain control of robotic arms. Their research specifically looks at using electrocorticography (ECoG), a method for recording brain activity, to enable paralyzed individuals to intuitively control robotic devices for tasks like reaching and grasping objects. This work aims to improve the quality of life for those affected by paralysis through innovative neuroprosthetic technology.

Dr. Martin Kampmann's lab at UCSF focuses on understanding the biological mechanisms behind Alzheimer's disease and related dementias. The lab investigates why certain neurons are more vulnerable to these diseases and explores potential therapeutic targets to improve resilience in these cells. They utilize advanced techniques including CRISPR and RNA sequencing to uncover the roles of specific genes and molecular pathways in neurodegeneration.

Dr. Bridget Ostrem's lab at UCSF focuses on developing new treatments for premature infants suffering from white matter injury, a common and serious type of brain damage. The lab uses innovative screening methods to find compounds that can promote the repair of damaged brain cells and conduct clinical trials to test the safety and efficacy of these treatments. This research aims to provide effective therapies for conditions like cerebral palsy and learning disabilities that can arise from these injuries.

Dr. David C. Perry's research lab focuses on understanding and improving the diagnosis and prognosis of behavioral variant frontotemporal dementia (bvFTD), a type of early-onset dementia. The lab studies patients over time to uncover clinical and biological differences that could help predict how the disease progresses. By combining neurological examinations, cognitive tests, and neuroimaging data, the goal is to enhance accurate diagnoses and tailor clinical care for patients and their families.

Dr. Alexander Pollen's lab at UCSF focuses on understanding how human brains are uniquely adapted to challenges like aging and stress. They study dopaminergic neurons, which are critical for movement and mood, to see how they cope with age-related stressors compared to those in other primates. By combining modern techniques like CRISPR and machine learning with stem cell-derived organoids, the lab aims to uncover the genetic changes that contribute to human brain plasticity and vulnerability to disorders.

Dr. Louis J. Ptacek's lab focuses on understanding the genetics and biology behind sleep regulation, particularly for individuals with 'Familial Natural Short Sleep' (FNSS), a condition where affected people need significantly less sleep than average yet feel rested. The lab studies various genes involved in sleep homeostasis using human samples and mouse models, aiming to discover new genetic factors that play a role in sleep patterns. Ultimately, this research could lead to better treatments for sleep disorders.

Dr. Howard J. Rosen's lab at UCSF focuses on improving the diagnosis of dementia within primary care settings, particularly for underserved communities. His research aims to develop effective tools that allow primary care providers to quickly and accurately identify cognitive impairments related to Alzheimer’s disease and other neurodegenerative disorders. By integrating clinical assessments with blood biomarkers and utilizing pre-visit questionnaires, the lab strives to enhance early diagnosis and support for patients and families.

Dr. Kevin Bender's lab at UCSF focuses on understanding and developing therapies for autism spectrum disorder (ASD) by investigating the role of the SCN2A gene. This gene, which affects neuronal sodium channels, is linked to various sensorimotor and behavioral deficits in mice modeled for ASD. The lab employs advanced CRISPR technology to potentially correct these deficiencies and improve cellular and behavioral functions in these models, paving the way for new treatments for severe forms of autism.

Dr. Ying-Hui Fu's lab at UCSF focuses on understanding how sleep quality and efficiency are regulated by the brain and nervous system. The lab studies individuals with genetic traits for natural short sleep, identifying specific genes that may lead to better sleep efficiency without negative health impacts. Using mouse models, the research explores the protective effects of quality sleep against neurodegenerative diseases, aiming to uncover mechanisms that could promote healthier aging and cognitive function.

Dr. Boon Lead Tee's lab at UCSF focuses on understanding how bilingualism impacts cognitive health, particularly in relation to Alzheimer's disease and related dementias. By studying diverse populations across multiple cultures and languages, the lab aims to uncover the ways bilingual experiences may contribute to cognitive resilience and longevity. This interdisciplinary approach combines neuroimaging, behavioral assessments, and social factors to better understand the complex relationships between language, cognition, and health.

Dr. Arnold Kriegstein's research lab focuses on understanding how the human brain develops and how its complexity relates to neurodevelopmental diseases like autism and schizophrenia. The lab uses innovative technologies to study both human tissue and stem cells to unravel the diversity of neural cells and their roles in brain function. By creating detailed brain atlases of both humans and non-human primates, the lab aims to uncover the fundamental processes of brain development and evolutionary distinctions, ultimately improving therapeutic strategies for brain-related disorders.

The research lab led by Dr. Gil Dan Rabinovici at UCSF focuses on improving the diagnosis of Alzheimer's disease and related dementias (ADRD). Their work seeks to validate accessible biomarkers and cognitive tests, particularly for underrepresented populations, to enhance diagnostic precision and inclusivity. Through collaboration with a multi-disciplinary team, they aim to develop scalable approaches to identify individuals who may benefit from disease-modifying therapies.

Dr. Elyssa Margolis' lab at UCSF focuses on understanding how specific brain circuits influence pain perception and its emotional aspects, particularly in the context of chronic pain and depression. The lab investigates the lateral habenula, a brain region involved in both sensory pain and mood disorders. By studying how this area connects to other brain structures, the lab aims to identify potential new therapies for alleviating both pain and the emotional distress that often accompanies it.

Dr. Kaitlin B. Casaletto's lab focuses on understanding how biological sex influences dementia, particularly frontotemporal dementia (FTD). They investigate the roles of sex hormones and synaptic health in cognitive resilience, aiming to unlock new strategies for the prevention and treatment of Alzheimer's disease and related forms of dementia. This research hopes to address significant gaps in the current understanding of dementia's impact on different sexes.

Dr. William A. Weiss's lab focuses on understanding and developing new therapies for aggressive brain cancers, particularly glioblastoma and medulloblastoma. By investigating mechanisms at the molecular level, such as how specific proteins regulate cancer cell growth, the lab aims to create targeted treatments that improve patient outcomes while minimizing side effects. Current research includes developing drugs that can effectively penetrate the blood-brain barrier and inhibit key cancer drivers in the brain.

Dr. Scott Zamvil's lab at UCSF focuses on understanding how immune system cells, particularly T cells and B cells, contribute to a condition known as MOG antibody-associated disease (MOGAD). This research aims to uncover the roles of these cells in causing damage to the central nervous system and explore potential new treatments. By studying how these immune responses develop and interact, the lab hopes to advance our knowledge of various autoimmune disorders.